In this study, we developed a new drug delivery system using anodic oxidation. The growth of a porous oxide layer on aluminum under anodic bias in various electrolytes has been studied for more than 40 years. Anodic Aluminum Oxide (AAO) has many uniform nanopores on its surface. This nanoporous surface can be used for drug storage. The effects of the diameter and depth of the AAO on the release characteristics of a drug were investigated. Paclitaxel was used for the drug loading and release test. Paclitaxel was loaded on the inside of the AAO by ultrasonication. The amount of the drug released from the AAO was analyzed by high performance liquid chromatography (HPLC). The pore size did not affect the drug release behavior. However, the depth of the pores had a significant influence on the release rate of the drug.
INTRODUCTION
Several reports have shown that the baseline and procedural characteristics influence the risk of restenosis after bare metal stent (BMS) implantation. [1] [2] [3] [4] To solve this problem, drug eluting stents (DESs) were suggested. Recently, DESs, such as sirolimus eluting and paclitaxel eluting stents, have been proved to markedly reduce the incidence of angiographic restenosis in selected patients. 5 6 In almost all cases, it is possible to coat the DES with a polymer in which the antiproliferative drug is embedded. However, it was found that the polymeric matrix on the stent might induce inflammation and thrombosis, which is a serious limitation of this application. 7 Drug delivery from porous structures has attracted a great deal of interest. 8 Anodic porous aluminum is one of the most attractive materials for use as a template with nanoporous structures for drug delivery applications. 9 10 The pore size and depth of AAO can easily be controlled by adjusting the anodizing voltage and time and the electrolyte composition. [11] [12] [13] A drug eluting stent made using AAO was reported by Wieneke et al. 14 In our previous studies, the feasibility of using AAO for drug eluting stents was investigated. 15 16 In this case, 2-deoxyadenosine was used as the drug for the loading and release test. However, it was almost completely released from the AAO in the incipient state of the in-vitro test, due to its water-soluble properties. Therefore, * Author to whom correspondence should be addressed. the effect of the pore structure on the drug release from AAO was not clearly examined.
In this study, Paclitaxel was used for the loading and release test. Paclitaxel is highly lipophilic and is essentially insoluble in water. 17 Since it inhibits cell proliferation, Paclitaxel is used as a mitotic inhibitor in cancer chemotherapy. The effect of the pore structure on the drug release from the AAO was not discussed. The control of the pore size and depth can change the loading space of the drug. Our interest in the application of AAO to drug delivery systems is focused on the effect of the pore size and depth of the AAO on the loading and release of the drug. The loading and release characteristics of AAO with various pore structures were examined and discussed.
EXPERIMENTAL DETAILS
Pure aluminum (Al) foils (99.999 wt%) with a thickness of 200 m were used in our experiment. The Al foil in the form of a rectangular cut out (4 cm × 1 cm) was used for the fabrication of the AAO template. Prior to anodizing them, the Al foils were electropolished in order to achieve a smooth surface. The electropolishing was performed at a constant current of 1.5 A below 25 C for 30 s in a mixture solution consisting of HClO 4 and C 2 H 5 OH at a volume ratio of 1:4 with magnetic stirring. The polished sample was then rinsed and air dried. Two-step anodization was performed. Two groups of samples were used to investigate the drug release behavior as a function of the All of the samples were cleaned by means of a sonosmasher (Ulsoo Hi-Tech) for 20 min and then dried in a dry oven at 80 C for 24 hrs. Then, the AAO surface was treated with oxygen (O 2 ) plasma in order to modify it. Paclitaxel (Samyang genex 99-100%, C 47 H 51 NO 14 ) and ethanol were mixed at a ratio of 1:10. The AAO sheets prepared using the different conditions were inserted into the Paclitaxel solution and sonicated by the sonosmasher for 2 hrs. The sheet was then perfectly dried in a dry oven at 80 C for 24 hrs. After putting the sample in 10 cc of phosphate buffered saline (PBS), we performed the release test every 24 hrs in an incubator at 36.5 C. ESEM (Environment Scanning Electron Microscopy) was used to characterize the morphology of the AAO template. Samples of the released drug were analyzed by HPLC on a Phenomenex Gemini C-18 column (5 m, 150 mm × 4 60 mm). Chromatographic separation was achieved by using a mobile phase consisting of methanol (Fisher co.) and DI-water (10:90 v/v for 10 min after 20:80 v/v) with a flow rate of 0.8 ml/min. The UV detector was set at 228 nm.
RESULTS AND DISCUSSION
The pore structure of the AAO film is shown in Figure 1 . Hexagonal ordered domains can be seen all over the AAO surface. Figure 1(a) shows the top and cross sectional images of the specimen, which was anodized in oxalic and phosphoric acid solution at a voltage of 40 V. The pore reduce the pore diameter by ALD. Pore diameters of about 50, 40 and 20 nm were obtained after the deposition of TiO 2 for the specimens in Figures 1(b) , (c) and (d), respectively. All of the samples have a uniform pore depth of 2 m. Figure 2 shows a part of the AAO before and after drug loading. Empty nanopores can be seen before drug loading in Figure 2(a) . However, almost all of the pores were filled with the drug after loading, as shown in Figure 2 (b). Columns with a bent shape can be seen in the cross section view (Fig. 2(b) ), which are considered to be made up of the drug. Figure 3 shows the plot of the cumulative drug release from the AAO films with different pore diameters. Even after 400 hr, the drug was still eluted steadily. The amounts of drug released from all of the specimens, except for the one with a pore diameter of 20-30 nm, were similar, despite the difference in the pore diameter. This result means that the drug release rate did not depend on the pore diameter. The amount of drug released from the specimen with a pore diameter of 20-30 nm was larger than that from the other specimens. However, the drug release tendency, except for the initial release period of 120 hr, was almost the same. It is believed that a large amount of the loaded drug was located on the surface of the specimen with a pore diameter of 20-30 nm after drug loading and was released in the early stages. In order to investigate the effect of the pore depth on the drug release, three different specimens with different thicknesses were prepared. First, using oxalic acid at 5 C as an electrolyte, three identical AAO specimens were produced with a pore diameter of 40-50 nm, as shown in Figure 4 . Then, three specimens with pore depths of 500 nm (a), 1 m (b), and 4 m (c) were produced by controlling the secondary anodization time. Figure 5 shows the plot of the cumulative drug release from the AAO films with different pore depths. Increasing the pore depth from 0.5 m to 4 m decreased the amount of drug released. In the kinetics of drug release, it is believed that the depth of the pores plays an important role, as in the case of a diffusion controlled reaction. When the drug release from the pores occurs through a diffusion controlled process, the release time is proportional to the square of the depth. However, the time-release curve showing the amount of drug released as a function of the pore depth in Figure 5 did not correspond to that of a diffusion controlled reaction. It is considered that the drug is released not only from the bottom, but also from the side walls of the pores. Therefore, the mean diffusion distance may be smaller than the pore depth.
CONCLUSION
AAO films were fabricated using a two-step anodizing process that resulted in a highly uniform pore size and depth distribution. The pore diameter and depth of the AAO film were controlled by adjusting the applied voltage and second anodization time during the anodizing process and ALD with TiO 2 . Paclitaxel was used for the drug loading and release test. The amount of drug released did not depend on the pore diameter. However, increasing the pore depth decreased the amount of drug released.
